. 2018 Apr 20;9(30):21100–21121. doi: 10.18632/oncotarget.24941

Table 1. The mutant-acquired PTEN^−/− characteristics reversed by overexpression TPTE2.

Characteristic	Relative level^b
Characteristic	MCF-10A	PTEN^−/−	PTEN^−/− TPTE2^oe
Wound healing, +GFs^a	+++	++++	++
Wound healing, +S, –other GFs^a	++	++++	+
Wound healing, –GFs^a Division rate, +GFs^a	– ++	++++ ++++	– ++
Viability, on 2D substrate, –GFs^a, undisturbed	–	++++	–
Adhesion on 2D substrate and long term viability, –GFs^a	–	++++	–
Viability in 3D matrix, –GFs^a	–	++++	–
Expression of annexin V surface binding site, +GFs^a	+++	–	++++

^a +GFs: plus growth factors. +S, –other GFs: plus serum, minus growth factors.

^b “Relative level” represents a comparison to the maximum measured amongst the three genotypes. Maximum is ++++, descending (+++, ++, +) to zero (−).

Table 1. The mutant-acquired PTEN−/− characteristics reversed by overexpression TPTE2.

Table 1. The mutant-acquired PTEN^−/− characteristics reversed by overexpression TPTE2.